Cryo-Cell International Inc. is a revolutionary company that has revolutionized the way expectant parents can provide their children with stem cell banking services. With Cryo-Cell, parents have access to both public and private cord blood banking programs, allowing them to cryopreserve their child's umbilical cord blood for future use. This innovative service provides an invaluable resource for those who may need it in the future, as cord blood is rich in hematopoietic stem cells which can be used to treat nearly 80 diseases including:

• Leukemia
• Lymphoma
• Anemia
• Inherited metabolic disorders

In addition to providing this valuable service, Cryo-Cell also intends to open infusion clinics where cellular therapies approved by the FDA will be administered under INDs (Investigational New Drug) applications in order to treat patients suffering from cerebral palsy, autism and traumatic brain injuries. To date over 40000 transplants worldwide have been performed using stem cells from umbilical cord blood thanks to Cryo-Cell's pioneering efforts - a testament of its commitment towards helping people lead healthier lives through cutting edge technology and medical advancements.

Overall, Cryo-Cell International Inc.'s dedication towards providing quality healthcare services makes it a leader in its field - one that should be commended for its tireless efforts towards improving the lives of countless individuals around the world.